Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis
BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM:...
Saved in:
Published in | Open access Macedonian journal of medical sciences Vol. 5; no. 2; pp. 160 - 166 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Macedonia
ID Design 2012/DOOEL Skopje
15.04.2017
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM: We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.MATERIAL AND METHODS: One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.RESULTS: The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.CONCLUSIONS: FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer. |
---|---|
AbstractList | Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.
We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.
One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.
The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.
FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer. BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.AIM: We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.MATERIAL AND METHODS: One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.RESULTS: The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.CONCLUSIONS: FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer. Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.BACKGROUNDBladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates have remained relatively constant over the past four decades. Urothelial bladder cancers have identified multiple risk factors.We aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.AIMWe aimed at evaluating the expression of the FGFR3 protein and gene amplification in the urothelial cells of neoplastic and non-neoplastic urothelial lesions of the urinary bladder, and correlation with tumour grade, stage and associated bilharziasis.One hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.MATERIAL AND METHODSOne hundred and five different urinary bladder lesions were studied, including 15 cystitis cases (9 bilharzial and 6 non-bilharzial cystitides), 75 urothelial carcinoma cases (18 bilharzial associated and 57 non-bilharzial associated) and 15 squamous cell carcinoma associated with bilharziasis, beside 5 control cases. Data concerning age, sex, tumour grade, stage, and associated bilharziasis were obtained. Each case was studied for FGFR3 expression, and FISH technique was applied on forty malignant cases that show high protein expression.The highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.RESULTSThe highest incidence of cystitis was in the fourth decade while of bladder cancer was in the seventh decade. Tumour grade was correlated significantly with tumour stage. FGFR3 correlates significantly with tumour grade, stage and with a bilharzial infestation. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours.FGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer.CONCLUSIONSFGFR3 overexpression in malignant cases was significantly higher than in chronic cystitis. FGFR3 gene amplification was reported mainly in low grade and NNMBIC tumours. FGFR3 may be further studied as a subject for target therapy of bladder cancer. |
Author | Khalil, Heba Badawy, Mohamed El Leithy, Tarek Al Osili, Khalid Kamel, Nora El Kholy, Amr Kamel, Amira Abdel-Hady, Ahmed Khairy, Hosni Hammam, Olfat Aboushousha, Tarek Akl, Maha Magdy, Mona El-Hindawi, Ali Anis, Shady |
AuthorAffiliation | 1 Theodor Bilharz Research Institute, Imbaba, Giza, Cairo, Egypt 2 Faculty of Medicine Cairo University, Cairo, Egypt 3 National Research Center5, El Doki, Giza, Egypt |
AuthorAffiliation_xml | – name: 2 Faculty of Medicine Cairo University, Cairo, Egypt – name: 1 Theodor Bilharz Research Institute, Imbaba, Giza, Cairo, Egypt – name: 3 National Research Center5, El Doki, Giza, Egypt |
Author_xml | – sequence: 1 givenname: Olfat surname: Hammam fullname: Hammam, Olfat – sequence: 2 givenname: Tarek surname: Aboushousha fullname: Aboushousha, Tarek – sequence: 3 givenname: Ali surname: El-Hindawi fullname: El-Hindawi, Ali – sequence: 4 givenname: Hosni surname: Khairy fullname: Khairy, Hosni – sequence: 5 givenname: Heba surname: Khalil fullname: Khalil, Heba – sequence: 6 givenname: Amira surname: Kamel fullname: Kamel, Amira – sequence: 7 givenname: Maha surname: Akl fullname: Akl, Maha – sequence: 8 givenname: Ahmed surname: Abdel-Hady fullname: Abdel-Hady, Ahmed – sequence: 9 givenname: Mona surname: Magdy fullname: Magdy, Mona – sequence: 10 givenname: Mohamed surname: Badawy fullname: Badawy, Mohamed – sequence: 11 givenname: Amr surname: El Kholy fullname: El Kholy, Amr – sequence: 12 givenname: Khalid surname: Al Osili fullname: Al Osili, Khalid – sequence: 13 givenname: Nora surname: Kamel fullname: Kamel, Nora – sequence: 14 givenname: Shady surname: Anis fullname: Anis, Shady – sequence: 15 givenname: Tarek surname: El Leithy fullname: El Leithy, Tarek |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28507621$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kcFvFCEUxompsbX27M1w9LJbYIYBLia16a4mm9hUeyYMvLE0DKww2-h_L-PWpm3SEyTv933v5fveooOYIiD0npJlI6U6TWa8HcuSESqWpJWv0BGVXCxUx_nBo_8hOinllhBCueooY2_QIZOciI7RIxQufm8zlOJTxGnAq_XqqsGXOU3gIzbR4TVEwGfjNvjBWzPNXJ1cZx9N_oM_B-McZLyB2aHMoysIe2xK-Lu98WVKJY3eFF_eodeDCQVO7t9jdL26-HH-ZbH5tv56frZZ2EZIuTCNawcQPRFM9a0gzEhHeKsGw8ApzqztqW0F7Y0SpgFHWSf73qnO2M7xdmiO0ae973bXj-AsxCmboLfZj_VonYzXTyfR3-if6U7zltVcRDX4eG-Q068dlEmPvlgIwURIu6KpVKolNURV0Q-Pdz0s-R9xBU73gM2plAzDA0KJnnvU-x713KOuPVYFf6awfvqXaT3Whxd1fwHXx6W9 |
CitedBy_id | crossref_primary_10_3889_oamjms_2023_11372 crossref_primary_10_3390_cells10051201 crossref_primary_10_3892_ijo_2019_4763 crossref_primary_10_1007_s11033_023_08370_z crossref_primary_10_1155_2020_8270810 |
Cites_doi | 10.1158/1535-7163.MCT-12-1150 10.1111/his.12473 10.1593/neo.07178 10.1002/hep.25956 10.1007/s10552-007-9104-7 10.1002/cam4.262 10.1136/jclinpath-2015-202898 10.1016/j.febslet.2009.09.021 10.1016/j.jare.2013.06.007 10.1016/j.juro.2011.09.008 10.1002/path.4334 10.1002/path.2207 10.1097/00001648-200111000-00022 10.1002/ijc.23547 10.1155/2012/429213 10.1186/1756-9966-28-27 10.1016/j.canep.2010.05.003 10.1186/1750-9378-8-19 |
ContentType | Journal Article |
Copyright | Copyright: © 2017 Olfat Hammam, Tarek Aboushousha, Ali El-Hindawi, Hosni Khairy, Heba Khalil, Amira Kamel, Maha Akl, Ahmed Abdel-Hady, Mona Magdy, Mohamed Badawy, Amr El Kholy, Khalid Al Osili, Nora Kamel, Shady Anis, Tarek El Leithy. 2017 |
Copyright_xml | – notice: Copyright: © 2017 Olfat Hammam, Tarek Aboushousha, Ali El-Hindawi, Hosni Khairy, Heba Khalil, Amira Kamel, Maha Akl, Ahmed Abdel-Hady, Mona Magdy, Mohamed Badawy, Amr El Kholy, Khalid Al Osili, Nora Kamel, Shady Anis, Tarek El Leithy. 2017 |
DBID | AAYXX CITATION NPM 7X8 5PM |
DOI | 10.3889/oamjms.2017.048 |
DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
DatabaseTitleList | PubMed CrossRef MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1857-9655 |
EndPage | 166 |
ExternalDocumentID | PMC5420767 28507621 10_3889_oamjms_2017_048 |
Genre | Journal Article |
GroupedDBID | 53G AAYXX ADBBV ADRAZ ALMA_UNASSIGNED_HOLDINGS AOIJS BCNDV CITATION C~G DYU HYE IPNFZ KQ8 M48 M~E OK1 PGMZT RIG RPM SLJYH GROUPED_DOAJ NPM 7X8 5PM ABFKT |
ID | FETCH-LOGICAL-c3788-a3d4fe7b0729b4702a8d0549fa2ed952ccb1c471ba97a3ed1268bbd96ac6d54f3 |
IEDL.DBID | M48 |
ISSN | 1857-9655 |
IngestDate | Thu Aug 21 13:39:14 EDT 2025 Thu Jul 10 18:45:40 EDT 2025 Thu Jan 02 22:26:57 EST 2025 Thu Apr 24 23:09:19 EDT 2025 Sun Jul 06 05:02:49 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | true |
Issue | 2 |
Keywords | FISH cystitis IHC carcinoma urothelial bladder lesions FGFR3 |
Language | English |
License | http://creativecommons.org/licenses/by-nc/4.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c3788-a3d4fe7b0729b4702a8d0549fa2ed952ccb1c471ba97a3ed1268bbd96ac6d54f3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3889/oamjms.2017.048 |
PMID | 28507621 |
PQID | 1899408509 |
PQPubID | 23479 |
PageCount | 7 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5420767 proquest_miscellaneous_1899408509 pubmed_primary_28507621 crossref_primary_10_3889_oamjms_2017_048 crossref_citationtrail_10_3889_oamjms_2017_048 |
PublicationCentury | 2000 |
PublicationDate | 2017-04-15 |
PublicationDateYYYYMMDD | 2017-04-15 |
PublicationDate_xml | – month: 04 year: 2017 text: 2017-04-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | Macedonia |
PublicationPlace_xml | – name: Macedonia – name: Republic of Macedonia |
PublicationTitle | Open access Macedonian journal of medical sciences |
PublicationTitleAlternate | Open Access Maced J Med Sci |
PublicationYear | 2017 |
Publisher | ID Design 2012/DOOEL Skopje |
Publisher_xml | – name: ID Design 2012/DOOEL Skopje |
References | 31250 31261 31260 31245 31256 31244 31255 31247 31258 31246 31257 31241 31252 31240 31251 31243 31254 31242 31253 31249 31248 31259 24519156 - J Pathol. 2014 Jun;233(2):148-58 18231634 - Neoplasia. 2008 Jan;10(1):1-7 20542753 - Cancer Epidemiol. 2010 Dec;34(6):724-32 23657946 - Mol Cancer Ther. 2013 Jul;12(7):1245-54 11245416 - Cancer Res. 2001 Feb 15;61(4):1265-8 19243595 - J Exp Clin Cancer Res. 2009 Feb 25;28:27 19761767 - FEBS Lett. 2009 Oct 6;583(19):3254-8 26251520 - J Clin Pathol. 2015 Oct;68(10):819-24 18478569 - Int J Cancer. 2008 Aug 1;123(3):601-8 11679802 - Epidemiology. 2001 Nov;12(6):719-26 24898159 - Histopathology. 2015 Apr;66(5):639-49 22099989 - J Urol. 2012 Jan;187(1):310-4 22899908 - Adv Urol. 2012;2012:429213 24846059 - Cancer Med. 2014 Aug;3(4):835-44 2713858 - Cancer Res. 1989 May 15;49(10):2750-4 22890726 - Hepatology. 2013 Apr;57(4):1407-15 23705833 - Infect Agent Cancer. 2013 May 24;8(1):19 17668422 - J Pathol. 2007 Sep;213(1):91-8 25685453 - J Adv Res. 2013 Sep;4(5):461-6 18188671 - Cancer Causes Control. 2008 May;19(4):421-9 |
References_xml | – ident: 31257 doi: 10.1158/1535-7163.MCT-12-1150 – ident: 31243 – ident: 31261 doi: 10.1111/his.12473 – ident: 31258 doi: 10.1593/neo.07178 – ident: 31253 doi: 10.1002/hep.25956 – ident: 31240 doi: 10.1007/s10552-007-9104-7 – ident: 31247 doi: 10.1002/cam4.262 – ident: 31259 doi: 10.1136/jclinpath-2015-202898 – ident: 31249 doi: 10.1016/j.febslet.2009.09.021 – ident: 31251 – ident: 31252 – ident: 31250 – ident: 31254 doi: 10.1016/j.jare.2013.06.007 – ident: 31245 doi: 10.1016/j.juro.2011.09.008 – ident: 31246 doi: 10.1002/path.4334 – ident: 31248 doi: 10.1002/path.2207 – ident: 31242 doi: 10.1097/00001648-200111000-00022 – ident: 31256 doi: 10.1002/ijc.23547 – ident: 31244 doi: 10.1155/2012/429213 – ident: 31255 doi: 10.1186/1756-9966-28-27 – ident: 31260 doi: 10.1016/j.canep.2010.05.003 – ident: 31241 doi: 10.1186/1750-9378-8-19 – reference: 22099989 - J Urol. 2012 Jan;187(1):310-4 – reference: 22890726 - Hepatology. 2013 Apr;57(4):1407-15 – reference: 24519156 - J Pathol. 2014 Jun;233(2):148-58 – reference: 20542753 - Cancer Epidemiol. 2010 Dec;34(6):724-32 – reference: 24846059 - Cancer Med. 2014 Aug;3(4):835-44 – reference: 18188671 - Cancer Causes Control. 2008 May;19(4):421-9 – reference: 26251520 - J Clin Pathol. 2015 Oct;68(10):819-24 – reference: 11679802 - Epidemiology. 2001 Nov;12(6):719-26 – reference: 23657946 - Mol Cancer Ther. 2013 Jul;12(7):1245-54 – reference: 23705833 - Infect Agent Cancer. 2013 May 24;8(1):19 – reference: 19761767 - FEBS Lett. 2009 Oct 6;583(19):3254-8 – reference: 18478569 - Int J Cancer. 2008 Aug 1;123(3):601-8 – reference: 18231634 - Neoplasia. 2008 Jan;10(1):1-7 – reference: 22899908 - Adv Urol. 2012;2012:429213 – reference: 11245416 - Cancer Res. 2001 Feb 15;61(4):1265-8 – reference: 25685453 - J Adv Res. 2013 Sep;4(5):461-6 – reference: 24898159 - Histopathology. 2015 Apr;66(5):639-49 – reference: 2713858 - Cancer Res. 1989 May 15;49(10):2750-4 – reference: 19243595 - J Exp Clin Cancer Res. 2009 Feb 25;28:27 – reference: 17668422 - J Pathol. 2007 Sep;213(1):91-8 |
SSID | ssj0001596122 |
Score | 2.0562387 |
Snippet | BACKGROUND: Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and... Bladder cancer represents the fifth most common malignancy worldwide and a major cause of cancer-related morbidity and death. Incidence and mortality rates... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 160 |
SubjectTerms | Basic Science |
Title | Expression of FGFR3 Protein and Gene Amplification in Urinary Bladder Lesions in Relation to Schistosomiasis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/28507621 https://www.proquest.com/docview/1899408509 https://pubmed.ncbi.nlm.nih.gov/PMC5420767 |
Volume | 5 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3dS-QwEA-egtyL-HXn-kUOfPCle9s0aZoHERVXOVTkzoI-laRJcWW31e0K-t8703ZXVz3wtZOkZfIxv-lMfkPIjhSORR0XeL6wzOMys3AO2swLXGaUCTRTpsryvQhPY_7nWly_lgNqFFh-6tphPal42G8_PTzvw4bfQ48zitTvQg_uBki97cs2LMhvZA7MksRdet5g_frKsAJrXkU_kf5IhULUVD-fjTFtpT5Az_cZlG9MUneRLDRYkh7Uk79EZly-TObPm2j5CukfPzVprjktMto96f4N6CUSM_RyqnNLkXOaHmBOedb8uqMgiYfVHV162MdTaUjPHI5QomicOkdHBf2XVlzFZTHo6bJXrpK4e3x1dOo11RW8FDnkPR1YnjlpkDrccNlhOrKA31SmmbNKsDQ1fgqmy2gldeCsz8LIGKtCnYZW8Cz4QWbzIndrhPoBdACJBWzDkQKMh4YrC1AkZVJ1ohZpj7WZpA31OFbA6CfggqD6k1r9Cao_AfW3yO6kw33NuvH_pr_G05PAzsBwh85d8VgmPriSyN_WUS3ys56uyWAMHoMZ8FtETk3kpAGybk9L8t5txb4tOIOucv0L790g3_EzMfjki00yOxo-ui3AMCOzDej9Jt6uVugLMnzzMQ |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Expression+of+FGFR3+Protein+and+Gene+Amplification+in+Urinary+Bladder+Lesions+in+Relation+to+Schistosomiasis&rft.jtitle=Open+access+Macedonian+journal+of+medical+sciences&rft.au=Hammam%2C+Olfat&rft.au=Aboushousha%2C+Tarek&rft.au=El-Hindawi%2C+Ali&rft.au=Khairy%2C+Hosni&rft.date=2017-04-15&rft.issn=1857-9655&rft.eissn=1857-9655&rft.volume=5&rft.issue=2&rft.spage=160&rft_id=info:doi/10.3889%2Foamjms.2017.048&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1857-9655&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1857-9655&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1857-9655&client=summon |